United States · Wires & real time · PR Newswire

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

Published by PR Newswire · United States 2 h ago

The physician-scientist helped advance landmark tumor-agnostic therapies that target cancer's genetic drivers. NEW YORK, Oct. 22, 2026 /PRNewswire/ -- NYU Langone Health today…

Read the full article on PR Newswire Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.prnewswire.com)

Also worth reading

Associated Press (Business)

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Business Wire

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Dow Jones Newswires

Perlmutter Cancer Center Taps Vivek Subbiah, MD, to Lead Early-Phase Drug Development and Rare Cancer Programs

Share

Also worth reading

The Ford Foundation, one of the world’s largest grantmakers, will throw more weight behind democracy

Lyric Releases Framework for Measuring Healthcare Decision Intelligence Maturity in Payment Accuracy

Advancing Government Intelligence: Insights From the Data and Intelligence Training Forum